Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

In vivo lysogenization of a Clostridium difficile bacteriophage –§CD119.

Revathi G, Fralick JA, Rolfe RD.

Anaerobe. 2011 Jun;17(3):125-9. doi: 10.1016/j.anaerobe.2011.05.012. Epub 2011 Jun 2.

2.

Bacteriophage-mediated toxin gene regulation in Clostridium difficile.

Govind R, Vediyappan G, Rolfe RD, Dupuy B, Fralick JA.

J Virol. 2009 Dec;83(23):12037-45. doi: 10.1128/JVI.01256-09. Epub 2009 Sep 23.

3.

Evidence that Clostridium difficile TcdC is a membrane-associated protein.

Govind R, Vediyappan G, Rolfe RD, Fralick JA.

J Bacteriol. 2006 May;188(10):3716-20.

4.
5.

In vitro and in vivo activities of nitazoxanide against Clostridium difficile.

McVay CS, Rolfe RD.

Antimicrob Agents Chemother. 2000 Sep;44(9):2254-8.

6.

The role of probiotic cultures in the control of gastrointestinal health.

Rolfe RD.

J Nutr. 2000 Feb;130(2S Suppl):396S-402S. doi: 10.1093/jn/130.2.396S. Review.

PMID:
10721914
7.

Binding of Clostridium difficile toxin A to human milk secretory component.

Dallas SD, Rolfe RD.

J Med Microbiol. 1998 Oct;47(10):879-88.

PMID:
9788811
8.
9.

Soluble plasma antigen in experimental Salmonella typhimurium infection in mice.

Butler T, Rolfe RD, James GM, Hentges DJ.

FEMS Immunol Med Microbiol. 1994 Oct;9(4):325-32.

PMID:
7866354
10.
13.

Diagnosis of Clostridium difficile-associated intestinal disease.

Rolfe RD.

Crit Rev Clin Lab Sci. 1986;24(3):235-61. Review.

PMID:
3539522
14.
15.
16.

Intestinal colonization of infant hamsters with Clostridium difficile.

Rolfe RD, Iaconis JP.

Infect Immun. 1983 Nov;42(2):480-6.

17.

Susceptibility testing of anaerobic bacteria.

Finegold SM, Rolfe RD.

Diagn Microbiol Infect Dis. 1983 Mar;1(1):33-40.

PMID:
6323094
18.
19.

Comparative in vitro activity of ceftriaxone against anaerobic bacteria.

Rolfe RD, Finegold SM.

Antimicrob Agents Chemother. 1982 Aug;22(2):338-41.

21.

Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis.

George WL, Rolfe RD, Harding GK, Klein R, Putnam CW, Finegold SM.

Infection. 1982;10(4):205-8.

PMID:
7129642
22.

Susceptibility of Clostridium septicum to 23 antimicrobial agents.

Gabay EL, Rolfe RD, Finegold SM.

Antimicrob Agents Chemother. 1981 Dec;20(6):852-3.

23.

Comparison of liquid growth media for Legionella pneumophila.

Saito A, Rolfe RD, Edelstein PH, Finegold SM.

J Clin Microbiol. 1981 Dec;14(6):623-7.

24.

Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.

Rolfe RD, Finegold SM.

Antimicrob Agents Chemother. 1981 Nov;20(5):600-9.

25.

Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity.

Vesely DL, Straub KD, Nolan CM, Rolfe RD, Finegold SM, Monson TP.

Infect Immun. 1981 Jul;33(1):285-91.

26.

Bacterial interference between Clostridium difficile and normal fecal flora.

Rolfe RD, Helebian S, Finegold SM.

J Infect Dis. 1981 Mar;143(3):470-5.

PMID:
6785366
27.

Rapid method that aids in distinguishing Gram-positive from Gram-negative anaerobic bacteria.

Halebian S, Harris B, Finegold SM, Rolfe RD.

J Clin Microbiol. 1981 Mar;13(3):444-8.

28.

Epidemiological aspects of Clostridium difficile-induced diarrhea and colitis.

Mulligan ME, George WL, Rolfe RD, Finegold SM.

Am J Clin Nutr. 1980 Nov;33(11 Suppl):2533-8. doi: 10.1093/ajcn/33.11.2533.

PMID:
7435425
29.

Treatment and prevention of antimicrobial agent-induced colitis and diarrhae.

George WL, Rolfe RD, Finegold SM.

Gastroenterology. 1980 Aug;79(2):366-72. No abstract available.

PMID:
7399244
30.

Relapse of pseudomembranous colitis after vancomycin therapy.

George WL, Volpicelli NA, Stiner DB, Richman DD, Liechty EJ, Mok HY, Rolfe RD, Finegold SM.

N Engl J Med. 1979 Aug 23;301(8):414-5. No abstract available.

PMID:
460343
31.

Infectious diseases 1979--antimicrobial agent-induced colitis: an update.

George WL, Rolfe RD, Mulligan ME, Finegold SM.

J Infect Dis. 1979 Aug;140(2):266-8. No abstract available.

PMID:
479645
32.

Purification and characterization of Clostridium difficile toxin.

Rolfe RD, Finegold SM.

Infect Immun. 1979 Jul;25(1):191-201.

33.

Diarrhea and colitis associated with antimicrobial therapy in man and animals.

George WL, Rolfe RD, Sutter VL, Finegold SM.

Am J Clin Nutr. 1979 Jan;32(1):251-7. Review.

PMID:
367148
34.

Factors related to the oxygen tolerance of anaerobic bacteria.

Rolfe RD, Hentges DJ, Campbell BJ, Barrett JT.

Appl Environ Microbiol. 1978 Aug;36(2):306-13.

35.

Oxygen tolerance of human intestinal anaerobes.

Rolfe RD, Hentges DJ, Barrett JT, Campbell BJ.

Am J Clin Nutr. 1977 Nov;30(11):1762-9. No abstract available.

PMID:
920635
36.

Effectiveness of palladium chloride for the isolation of anaerobes.

Owens DR, Rolfe RD, Hentges DJ.

J Clin Microbiol. 1976 Feb;3(2):218-20.

Supplemental Content

Loading ...
Support Center